Efficacy of a new aluminium salt thermophobic foam in the treatment of axillary and palmar primary hyperhidrosis: A pilot exploratory trial

Current Medical Research and Opinion

Volumn 21, Issue 12, 2005, Pages 1949-1953

  Innocenzi, Daniele ^a   Lupi, Francesca ^a   Bruni, Francesca ^a   Frasca, Mirko ^a   Panetta, Chiara ^a   Milani, Massimo ^b,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Research and Development   (Italy)

^c NONE   (Italy)

Author keywords

Aluminium salts; Idiopathic hyperhidrosis; Thermophobic foam

Indexed keywords

ALUMINUM SALT; SESQUICHLORHYDRATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AXILLARY LYMPH NODE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; EVALUATION; FEMALE; FOAM; FOLLOW UP; HUMAN; HYPERHIDROSIS; MALE; MEDICAL ASSESSMENT; PATIENT MONITORING; QUALITY OF LIFE; SAMPLE SIZE; SCORING SYSTEM; SWEAT GLAND; SWEAT TEST; TREATMENT OUTCOME;

ADULT; ALUMINUM COMPOUNDS; AXILLA; FEMALE; HAND; HUMANS; HYPERHIDROSIS; MALE; MIDDLE AGED; PILOT PROJECTS;

EID: 29144467052     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X74899     Document Type: Article

References (19)

1. Leung AK, Chan PY, Choi MC. Hyperhidrosis. Int J Dermatol 1999;38:561-7
2. Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. CMAJ 2005;172:69-75
3. Strutton DR, Kowalsky JW, Glaser A, et al. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 2004;51:241-24
4. Kinkelin I, Hund M. Effective treatment of frontal hyperhidrosis with botulinum toxin. Br J Dermatol 2000;143:824-7
5. Ramos R, Moya J. Primary hyperhidrosis and anxiety: a prospective preoperative survey of 158 patients. Arch Bronconeumol 2005;41:88-92
6. Amir M, Arish A Weinstein Y. Impairment in quality of life among patients seeking surgery for hyperhidrosis: preliminary results. Isr J Psychiatric Relat Sci 2000;37:25-31
7. Hashmonai M, Kopelman D, Assalia A. The treatment of primary palmar hyperhidrosis: a review. Surg Today 2000;30:211-8
8. White JW. Treatment of primary hyperhidrosis. Mayo Clin Proc 1986;61:951-6
9. Bouman H. The treatment of hyperhidrosis of hands and feet with constant current. Am J Phy Med 1952;31:158-69
10. Connolly M, De Berker D. Management of primary hyperhidrosis. Am J Clin Dermatol 2003;4:681-97
11. Lin TS, Fang HY. Transthoracic endoscopic sympathectomy in the treatment of palmar hyperhidrosis. Surg Neurol 1999;52:453-7
12. Simpson LL. Molecular pharmacology of botulinum toxin and tetanus toxin. Ann Rev Pharmacol Toxicol 1986;26:427-53
13. Franz TJ, Parsell DA, Halualani RM. Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy. Int J Dermatol 1999;38:628-32
14. Housman T, Mellen B, Rapp S. Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis 2002;70:327-32
15. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6
16. Minor V. Ein neues Verfahren zu der klinischen Untersuchung der Schweissabsonderung. Dtsch Z Nervenheilkd 1927;101:301-6
17. Naver H, Aquilonius SM. The treatment of focal hyperhidrosis with botulinum toxin. Eur J Neurol 1997;4:S75-9
18. Naumann M, Hamm H. Botulinum toxin type A in the treatment of focal, axillary and palmar hyperhidrosis and other hyperhidrotic conditions. Eur J Neurol 1999;6:S111-5
19. Nair B, Yamarik TA. Final report on the safety assessment of aluminium starch octenylsuccinate. Int J Toxicol 2002;21(Suppl 1):1-7